Concordance Between Iothalamate and Iohexol Plasma Clearance

Slides:



Advertisements
Similar presentations
The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Advertisements

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD 
Renal Function Testing
Diagnosis and Treatment of Hyponatremia
Peritoneal dialysis American Journal of Kidney Diseases
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc 
Reevaluation by High-Performance Liquid Chromatography: Clinical Significance of Microalbuminuria in Individuals at High Risk of Cardiovascular Disease.
Colin R. Lenihan, MB, BCh, BAO, Jane C. Tan, MD, PhD 
Petter Bjornstad, Amy B. Karger, David M. Maahs 
Metabolic Complications in Elderly Adults With CKD
Quiz Page March 2008 American Journal of Kidney Diseases
Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N
Measuring GFR Using the Plasma Clearance of 99mTc-DTPA
A Decade After the KDOQI CKD Guidelines
Impact of Comorbidities on Mortality in Managed Care Patients With CKD
Renal Manifestations of Plasma Cell Disorders
Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective  J. Michael Lazarus, MD, Raymond M. Hakim,
What Is the Goal With Endogenous Filtration Markers—Estimation of GFR or Prediction of Kidney Outcomes?  Andrew D. Rule, MD, MSc, Kent R. Bailey, PhD,
From Static to Dynamic Risk Prediction: Time Is Everything
Evaluation of the Potential Living Kidney Donor
Masaru Horio  American Journal of Kidney Diseases 
Hai-yan Wang, MD, American Journal of Kidney Diseases
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Salt and Hypertension American Journal of Kidney Diseases
Karl D. Nolph, MD, American Journal of Kidney Diseases
Effect of Protein Restriction on Serum and Urine Phosphate in the Modification of Diet in Renal Disease (MDRD) Study  Britt Newsome, MD, Joachim H. Ix,
Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
Tariq Shafi, MBBS, MHS, Andrew S. Levey, MD, Lesley A
Polyunsaturated Fatty Acids and Kidney Disease
Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia  Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
Performance of GFR Estimating Equations Stratified by Measured or Estimated GFR: Implications for Interpretation  Jonas Björk, PhD, Anders Grubb, MD,
Evaluation of GFR Measurement Method as an Explanation for Differences Among GFR Estimation Equations  Shan-Shan Dai, MMed, Yoshinari Yasuda, MD, Chun-Li.
American Journal of Kidney Diseases
Quiz Page April 2008 American Journal of Kidney Diseases
Study Designs in Patient-Oriented Research
The Precision of Standardized Hospitalization, Readmission, and Mortality Ratios for Dialysis Facilities  Steven M. Brunelli, MD, MSCE, Adam G. Walker,
Shirley J. Dopson, DO, Subramoniam Jayakumar, MD, Juan Carlos Q
Drug Dose Adjustments in Patients With Renal Impairment
Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD 
Sulfamethoxazole Crystalluria
Comparisons of Technetium-99m Diethylenetriaminepentaacetic Acid Plasma Clearance and Renal Dynamic Imaging With Inulin Clearance  Ling-I. Chen, MD, Mei-Chuan.
Lesley A. Stevens, MD, MS, Nicholas Stoycheff, MD 
Thiazide Responsiveness Testing in Patients With Renal Magnesium Wasting and Correlation With Genetic Analysis: A Diagnostic Test Study  Anneke P. Bech,
Quiz Page August 2007 American Journal of Kidney Diseases
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
Arnold S. Relman, MD, American Journal of Kidney Diseases
Trial Quality in Nephrology: How Are We Measuring Up?
Removal of Dabigatran by Hemodialysis
Making Music American Journal of Kidney Diseases
Differences in Blood Transfusion Trends Between US and UK Centers
American Journal of Kidney Diseases
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Quiz Page June 2009 American Journal of Kidney Diseases
MicroRNAs: A Macroview Into Focal Segmental Glomerulosclerosis
Jordi Goldstein-Fuchs, DSc, RD, RN, Denis Fouque, MD, PhD 
This Month in AJKD American Journal of Kidney Diseases
How to Manage Functional Vitamin K Deficiency in CKD
Quiz Page November 2005 American Journal of Kidney Diseases
Increased Plasma Levels of Tacrolimus After Ingestion of Green Tea
Dialysis Research and N-of-1 Trials: Made for Each Other?
Quiz Page January 2010 American Journal of Kidney Diseases
Serum Leptin and Epoetin Sensitivity
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
In Reply to ‘Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling’  Tariq Shafi, MBBS, MHS, Andrew S. Levey, MD, Josef.
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Quiz page December 2003 American Journal of Kidney Diseases
Presentation transcript:

Concordance Between Iothalamate and Iohexol Plasma Clearance Pierre Delanaye, MD, PhD, François Jouret, MD, PhD, Caroline Le Goff, EuSpLM, Etienne Cavalier, EuSpLM, PhD  American Journal of Kidney Diseases  Volume 68, Issue 2, Pages 329-330 (August 2016) DOI: 10.1053/j.ajkd.2016.01.007 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Passing-Bablok regressions: comparison of GFR measured by iohexol (y-axis) and iothalamate (x-axis). With iohexol measured by HPLC (high-performance liquid chromatography; left panel), the equation for the regression line (black line; with 95% confidence intervals) is y = 0.88x + 7 (0.82, 0.94; 3, 11). With iohexol measured by LC-MS/MS (liquid chromatography–tandem mass spectrometry; right panel), the equation for the regression line (black line; with 95% confidence intervals) is y = 0.88x + 1 (0.85, 0.92; −1, 4). The grey line is the identity line. American Journal of Kidney Diseases 2016 68, 329-330DOI: (10.1053/j.ajkd.2016.01.007) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Bland-Altman analysis: comparison of GFR measured by iohexol and iothalamate (iohexol measured by HPLC [left], iohexol measured by LC-MS/MS [right]). American Journal of Kidney Diseases 2016 68, 329-330DOI: (10.1053/j.ajkd.2016.01.007) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions